| XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway X Chen, D Iliopoulos, Q Zhang, Q Tang, MB Greenblatt, M Hatziapostolou, ... Nature 508 (7494), 103-107, 2014 | 833 | 2014 |
| An injectable nanoparticle generator enhances delivery of cancer therapeutics R Xu, G Zhang, J Mai, X Deng, V Segura-Ibarra, S Wu, J Shen, H Liu, ... Nature biotechnology 34 (4), 414-418, 2016 | 270 | 2016 |
| Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics J Shen, HC Kim, H Su, F Wang, J Wolfram, D Kirui, J Mai, C Mu, LN Ji, ... Theranostics 4 (5), 487, 2014 | 190 | 2014 |
| Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination S Persano, ML Guevara, Z Li, J Mai, M Ferrari, PP Pompa, H Shen Biomaterials 125, 81-89, 2017 | 153 | 2017 |
| SMAD4 gene mutation renders pancreatic cancer resistance to radiotherapy through promotion of autophagy F Wang, X Xia, C Yang, J Shen, J Mai, HC Kim, D Kirui, Y Kang, ... Clinical Cancer Research 24 (13), 3176-3185, 2018 | 145 | 2018 |
| Targeting autocrine CCL5–CCR5 axis reprograms immunosuppressive myeloid cells and reinvigorates antitumor immunity Y Ban, J Mai, X Li, M Mitchell-Flack, T Zhang, L Zhang, L Chouchane, ... Cancer research 77 (11), 2857-2868, 2017 | 129 | 2017 |
| Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery H Shen, C Rodriguez-Aguayo, R Xu, V Gonzalez-Villasana, J Mai, ... Clinical Cancer Research 19 (7), 1806-1815, 2013 | 120 | 2013 |
| A liposome encapsulated ruthenium polypyridine complex as a theranostic platform for triple-negative breast cancer J Shen, HC Kim, J Wolfram, C Mu, W Zhang, H Liu, Y Xie, J Mai, H Zhang, ... Nano letters 17 (5), 2913-2920, 2017 | 115 | 2017 |
| High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics J Shen, R Xu, J Mai, HC Kim, X Guo, G Qin, Y Yang, J Wolfram, C Mu, ... ACS nano 7 (11), 9867-9880, 2013 | 115 | 2013 |
| Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy J Shen, HC Kim, C Mu, E Gentile, J Mai, J Wolfram, L Ji, M Ferrari, Z Mao, ... Advanced healthcare materials 3 (10), 1629-1637, 2014 | 109 | 2014 |
| Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response X Xia, J Mai, R Xu, JET Perez, ML Guevara, Q Shen, C Mu, HY Tung, ... Cell reports 11 (6), 957-966, 2015 | 103 | 2015 |
| Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages M Song, OO Yeku, S Rafiq, T Purdon, X Dong, L Zhu, T Zhang, H Wang, ... Nature communications 11 (1), 6298, 2020 | 87 | 2020 |
| Multistage Vectored siRNA Targeting Ataxia‐Telangiectasia Mutated for Breast Cancer Therapy R Xu, Y Huang, J Mai, G Zhang, X Guo, X Xia, EJ Koay, G Qin, DR Erm, ... Small 9 (9‐10), 1799-1808, 2013 | 75 | 2013 |
| Improved antigen cross-presentation by polyethyleneimine-based nanoparticles J Chen, Z Li, H Huang, Y Yang, Q Ding, J Mai, W Guo, Y Xu International journal of nanomedicine, 77-84, 2011 | 75 | 2011 |
| Bone marrow endothelium-targeted therapeutics for metastatic breast cancer J Mai, Y Huang, C Mu, G Zhang, R Xu, X Guo, X Xia, DE Volk, GL Lokesh, ... Journal of controlled release 187, 22-29, 2014 | 64 | 2014 |
| A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells J Mai, S Song, M Rui, D Liu, Q Ding, J Peng, Y Xu Journal of Controlled Release 139 (3), 174-181, 2009 | 59 | 2009 |
| Recent advances in discovering the role of CCL5 in metastatic breast cancer A Khalid, J Wolfram, I Ferrari, C Mu, J Mai, Z Yang, Y Zhao, M Ferrari, ... Mini reviews in medicinal chemistry 15 (13), 1063-1072, 2015 | 58 | 2015 |
| A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells H Liu, J Mai, J Shen, J Wolfram, Z Li, G Zhang, R Xu, Y Li, C Mu, Y Zu, X Li, ... Theranostics 8 (1), 31, 2018 | 49 | 2018 |
| Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties J Peng, Y Zhao, J Mai, WK Pang, X Wei, P Zhang, Y Xu Journal of general virology 86 (12), 3227-3234, 2005 | 46 | 2005 |
| PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis C Rodriguez-Aguayo, E Bayraktar, C Ivan, B Aslan, J Mai, G He, ... EBioMedicine 40, 290-304, 2019 | 43 | 2019 |
Yuhong XuDali UniversityVerified email at dali.edu.cn
